Affiliation:
1. Departments of Basic and Clinical Immunology and of Enteropathogenic Bacteria, Finlay Institute, Habana City, Cuba
Abstract
ABSTRACT
The correlate of protection for serogroup B meningococci is not currently known, but for serogroup C it is believed to be the serum bactericidal assay (SBA). The current SBAs are labor intensive and the variations in protocols among different laboratories make interpretation of results difficult. A colorimetric SBA (cSBA), based on the ability of
Neisseria meningitidis
serogroup B to consume glucose, leading to acid production, was standardized by using group B strain Cu385-83 as the target. The cSBA results were compared to those obtained for a traditional colony-counting microassay (mSBA). Glucose and bromocresol purple pH indicator were added to the medium in order to estimate growth of cSBA target cell survivors through color change. Different variants of the assay parameters were optimized: growth of target cells (Mueller Hinton agar plates), target cell number (100 CFU/per well), and human complement source used at a final concentration of 25%. After the optimization, three other group B strains (H44/76, 490/91, and 511/91) were used as targets for the cSBA. The selection of the assay parameters and the standardization of cSBA were done with 13 sera from vaccinated volunteers. The titers were determined as the higher serum dilution that totally inhibited the bacterial growth marked by the color invariability of the pH indicator. This was detected visually as well as spectrophotometrically and was closely related to a significant difference in the growth of target cell survivors determined using Student’s
t
test. Intralaboratory reproducibility was ±1 dilution. The correlation between bactericidal median titers and specific immunoglobulin G serum concentration by enzyme immunoassay was high (
r
= 0.910,
P
< 0.01). The bactericidal titers generated by the cSBA and the mSBA were nearly identical, and there was a high correlation between the two assays (
r
= 0.974,
P
< 0.01). The standardized cSBA allows easy, fast, and efficient evaluation of samples.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference29 articles.
1. Bartoloni, A., F. Norelli, C. Ceccarini, R. Rappuoli, and P. Constantino. 1995 Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide. Vaccine13:463–470.
2. Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of Protection
3. Boslego, J., J. García, C. Cruz, W. Zollinger, B. Brandt, R. Ruiz, M. Martinez, J. Arthur, P. Underwood, W. Silva, E. Moran, W. Hankins, J. Gilly, J. Mays, and the Chilean National Committee for meningococcal Disease. 1995. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine13:821–829.
4. Camaraza, M. A., F. Sotolongo, A. Arnet, L. Izquierdo, C. Campa, T. Leiva, and G. Sierra. 1995. Respuesta de anticuerpos bactericidas a la vacunación con VA-MENGOC-BC en niños afectados por el accidente nuclear de Chernobil. Rev. Chil. Ped.66:31–33.
5. Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献